CClinicalTrials.gg
CompletedNCT04819594Updated May 2, 2022

The Effects of Aromatherapy on the Stress Levels of Nurses Working in an Urban, Safety-Net Community Hospital

An interventional study of Elequil aromatabs ® in Stress Levels, sponsored by Parkland Health and Hospital System. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-02.

Sponsored by Parkland Health and Hospital System · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
319
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Parkland Hospital inpatient nursing staff will be the focus of this study. This project aims to investigate the use of lavender on the stress levels associated with the nursing role. Nurses will wear the Elequil aromatabs ® over a four-hour period and a post survey will be given to assess root cause of stress and changes related to intervention.

Read the detailed description

Nurses today are facing unprecedented patient acuities, burnout, fear, uncertainty, a continuously evolving workflow and nursing shortages, Therefore, workplace-related stress has become one of today's most serious occupational hazards. Aromatherapy can be a convenient, inexpensive, and non-invasive method of stress relief. There is little research regarding the efficacy of aromatherapy by means of inhaling essential oils in reducing workplace stress-related symptoms among nurses. Therefore, this study will examine the efficacy of lavender-scented aromatherapy tabs (Elequil ® aromatabs ®) in reducing job stress-related symptoms among nurses.

The study for the participants goes as follows:

  1. Nurse identified by:

    • Leadership
    • Self-identified
    • SPARKS member
  2. Process:

    • Identified nurse will be informed and consented regarding the study.
    • An aromatab will be given to the nurse.
    • They will place the aromatab on their uniform top to allow for continuous exposure to the scent.
    • Four (4) hours later - nurse completes survey as to the effects of the aromatab
    • Completed survey is placed in research file at charge nurse desk in opaque folder.

Data to be used within the research project will be obtained from the collected survey forms.

Recruitment will be completed face-to-face between the SPARKS team member, leadership, or self -identification of the potential subject. Considerable care will be taken so that the person contacted does not feel pressured to participate.

The research team will meet prior to enrolling the first participant, during and upon completion of data collection. Any safety concerns will be addressed at those times. At any time during data collection, the PI's or any study team members may request that the team meets to address a safety concern. Study participants will be assured of anonymity and confidentiality of the data and they will also be reminded that they can withdraw from the study at any time.

02

Conditions studied

  • Stress Levels
03

In context

Lead sponsor

Parkland Health and Hospital System is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Nurses volunteering to participate in the study and are experiencing stress while at work

Exclusion criteria

Exclusion Criteria:

  • Known allergies or sensitivities to aromatherapy products, a history of respiratory problems, asthma, allergies to fragrance, or lost sense of smell. Those nurses who have had serious disease complications will also be excluded from the study.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
319 participants (actual)

Study arms

  • Experimental
    Study Group

    Nurses will wear the Elequil aromatabs ® (100% pure essential oil) over a four-hour period

    Other: Elequil aromatabs ®

Interventions

  • OtherElequil aromatabs ®

    100% pure essential oils in a unique controlled delivery system for relaxation, comfort, and sleep. Scented tabs on a self-adhesive label will be placed on the nurses's uniform for 4 hours to provide aromatherapy for the clinical setting.

06

What researchers measure

Primary outcomes

  1. Mean change in stress levels as measured by Nurse Survey

    Nurse Survey is used for measuring the level of stress in nurses who agree that the intervention reduced their stress levels. Possible scores range from 0 - 10 with higher scores indicating severe stress levels (worse outcome).

    Time frame: Baseline, 4 hours post intervention (aromatherapy)

07

Study locations

1 site
  • Parkland Health and Hospital System
    Dallas, Texas 75235, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04819594
Lead sponsor
Parkland Health and Hospital System
Responsible party
Justin Buchert (Quality Specialist, Parkland Health and Hospital System) — Principal investigator
First posted
Mar 29, 2021
Start date
Jun 1, 2021
Primary completion
Oct 1, 2021
Completion
Oct 31, 2021
Last update
May 2, 2022

Study contacts

Justin Buchert, MSN, M.Ed., MS, RN
principal investigator · Parkland Health and Hospital System

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion